News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,703 Results
Type
Article (40849)
Company Profile (253)
Press Release (665601)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (206074)
Career Advice (2028)
Deals (35768)
Drug Delivery (95)
Drug Development (81735)
Employer Resources (173)
FDA (16361)
Job Trends (15002)
News (348484)
Policy (32901)
Tag
Academia (2604)
Accelerated approval (5)
Adcomms (21)
Allergies (89)
Alliances (50109)
ALS (91)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (129)
Approvals (16362)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (16)
Bankruptcy (361)
Best Places to Work (11703)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (179)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (285)
Cancer (2301)
Cardiovascular disease (179)
Career advice (1697)
Career pathing (30)
CAR-T (153)
Cell therapy (436)
Cervical cancer (20)
Clinical research (66552)
Collaboration (853)
Company closure (1)
Compensation (551)
Complete response letters (19)
COVID-19 (2651)
CRISPR (42)
C-suite (250)
Cystic fibrosis (103)
Data (2281)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (275)
Diagnostics (6439)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87298)
Editorial (37)
Employer branding (21)
Employer resources (147)
Events (113367)
Executive appointments (737)
FDA (17686)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (774)
Gene editing (112)
Generative AI (20)
Gene therapy (315)
GLP-1 (716)
Government (4472)
Grass and pollen (6)
Guidances (108)
Healthcare (19000)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2800)
Inflammatory bowel disease (146)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (316)
IPO (16608)
IRA (40)
Job creations (3707)
Job search strategy (1439)
Kidney cancer (10)
Labor market (40)
Layoffs (474)
Leadership (17)
Legal (7985)
Liver cancer (76)
Lung cancer (323)
Lymphoma (156)
Machine learning (8)
Management (59)
Manufacturing (320)
MASH (71)
Medical device (13571)
Medtech (13576)
Mergers & acquisitions (19725)
Metabolic disorders (700)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1929)
NextGen: Class of 2025 (6613)
Non-profit (4522)
Now hiring (40)
Obesity (370)
Opinion (204)
Ovarian cancer (77)
Pain (92)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (239)
Patient recruitment (116)
Peanut (48)
People (57820)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase I (20729)
Phase II (29308)
Phase III (21847)
Pipeline (1286)
Policy (143)
Postmarket research (2590)
Preclinical (8820)
Press Release (65)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (249)
Rare diseases (383)
Real estate (6024)
Recruiting (65)
Regulatory (22564)
Reports (46)
Research institute (2354)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (71)
Series A (131)
Series B (89)
Service/supplier (11)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3619)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (45)
The Weekly (30)
Vaccines (725)
Venture capitalists (41)
Weight loss (237)
Women's health (35)
Worklife (16)
Date
Today (291)
Last 7 days (867)
Last 30 days (2911)
Last 365 days (32829)
2025 (11347)
2024 (35412)
2023 (40300)
2022 (51419)
2021 (56032)
2020 (54576)
2019 (46983)
2018 (35407)
2017 (32531)
2016 (31889)
2015 (38026)
2014 (31798)
2013 (26762)
2012 (29008)
2011 (29665)
2010 (27700)
Location
Africa (736)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38462)
Australia (6274)
California (6276)
Canada (2048)
China (532)
Colorado (270)
Connecticut (275)
Delaware (153)
Europe (84733)
Florida (928)
Georgia (209)
Idaho (58)
Illinois (547)
India (25)
Indiana (315)
Iowa (11)
Japan (167)
Kansas (105)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (916)
Massachusetts (4685)
Michigan (222)
Minnesota (398)
Mississippi (2)
Missouri (81)
Montana (28)
Nebraska (25)
Nevada (65)
New Hampshire (63)
New Jersey (1764)
New Mexico (28)
New York (1784)
North Carolina (1005)
North Dakota (8)
Northern California (2752)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1409)
Puerto Rico (12)
Rhode Island (33)
South America (1118)
South Carolina (25)
South Dakota (1)
Southern California (2357)
Tennessee (103)
Texas (936)
United States (23658)
Utah (187)
Virginia (150)
Washington D.C. (64)
Washington State (557)
West Virginia (3)
Wisconsin (57)
706,703 Results for "pari respiratory equipment inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
February 25, 2025
·
2 min read
BioMidwest
Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr).
June 25, 2024
·
2 min read
Press Releases
Pneuma Respiratory Advances Inhaled Therapeutics to Improve Respiratory Health
February 17, 2025
·
3 min read
Press Releases
Caliway to Present CBL-514 Phase 2b Study Results for Subcutaneous Fat Reduction at IMCAS 2025 in Paris
December 18, 2024
·
4 min read
Press Releases
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
April 30, 2025
·
3 min read
Drug Development
Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
Biophytis SA, a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, presented the roll-out and results of its phase 2/3 COVA study in the treatment of severe forms of Covid-19 at the 6th edition of the World Congress on Infectious Diseases, held from June 24 to 26, 2024 in Paris, France.
July 1, 2024
·
4 min read
Press Releases
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
April 17, 2025
·
7 min read
Press Releases
Equipment Junction Turns Surplus Lab Gear into STEM Opportunities
April 1, 2025
·
1 min read
Press Releases
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
April 9, 2025
·
4 min read
Press Releases
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
December 16, 2024
·
4 min read
1 of 70,671
Next
